Composition
- Active ingredients
- INOTERSEN SODIUM EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA211172.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tegsedi
- Active substance
- inotersen sodium
- Drug class
- Other nervous system drugs
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Akcea Theraps
- Status
- Discontinued
- FDA approval
- 5 Oct 2018
- Application
- NDA211172-001
- RxCUI
- 2099319